Intellia Therapeutics, Inc. (NTLA)
13.69
+0.01
(+0.07%)
USD |
NASDAQ |
May 29, 11:55
Intellia Therapeutics EPS Diluted (Quarterly) : -0.8121 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Twist Bioscience Corp. | -0.7134 |
| KalVista Pharmaceuticals, Inc. | -0.4303 |
| Beam Therapeutics, Inc. | -0.9134 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -96.23M |
| Revenue (Quarterly) | 15.05M |
| Total Expenses (Quarterly) | 111.28M |
| Enterprise Value | 1.616B |
| Gross Profit Margin (Quarterly) | 85.37% |
| Profit Margin (Quarterly) | -639.5% |
| Earnings Yield | -25.82% |
| Normalized Earnings Yield | -25.85 |